As the prevalence of dementia continues to rise, experts are grappling with the implications of this disease on end-of-life care and the accuracy of medical record documentation.

Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life expectancy also brings an increase in the number of diseases, ...

Zanesville, OH- Every 65 seconds, someone in the U.S. receives a troubling diagnosis.  Alzheimer’s disease, which has no cure ...

Knoxville breweries are joining forces this month for the 2025 Ales for Alz Beer Trail, benefiting the Knoxville Walk to End Alzheimer’s.

Dementia Friends Minnesota empowers communities to create compassionate spaces, fostering understanding and support for those ...

The FDA cleared the use of the first approved blood test that can help diagnose Alzheimer’s disease. Learn more from U of U ...

Researchers at the Carney Institute for Brain Science have identified electrical activity in the brain that could predict ...

Donanemab, approved by the FDA in 2024 to treat Alzheimer's disease, is a monoclonal antibody directed at N-terminally ...

The Alzheimer’s Association held its international conference in Toronto. The conference unveiled new research about ...

Patients with breast cancer who undergo chemotherapy may face an increased risk for brain atrophy and cognitive decline, new ...

At AAIC, Lilly highlighted benefits of being able to stop Kisunla, while Eisai made a case for subcutaneous Leqembi, which is ...

Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.